New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma
Today, it is difficult to overestimate the new directions in the pharmacotherapy of peripheral T-cell lymphomas (PTCL): immunotherapy, including adoptive, targeted therapy and chemotherapy. However, there are few biomarkers that predict response to therapy. A big problem is patients with refractory...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
IRBIS LLC
2023-07-01
|
| Edice: | Фармакоэкономика |
| Témata: | |
| On-line přístup: | https://www.pharmacoeconomics.ru/jour/article/view/807 |